SHR-3276

SHR-3276 · Suzhou Suncadia Biopharmaceuticals Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SHR-3276, covering 2025-01-08 to 2025-01-08. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Study of SHR-3276 for Injection in Patients With Advanced Malignant Tumors [Phase 1, Phase 2]